Younseop Chung

Younseop Chung currently serves as Board Director and Vice President in Residence for Strategy at VantAI, where non-technical strategy development is a key focus. Since August 2019, Younseop has been a Project Leader at SK Group, engaging in corporate strategy development and investment in AI drug discovery and bio-tech across multiple roles, including positions at the Bio Investment Center. Prior experience includes consultancy at Proteovant Therapeutics, where value-up strategy development was emphasized, and new business initiatives at Kakao Corp. Younseop's career also includes venture investment at Samsung Electronics, specializing in deep-tech, and roles within the Republic of Korea Navy, focusing on defense industry cooperation and naval warfare system management. Educational credentials include a Bachelor's degree in Economics & Finance from Queen Mary University of London and participation in the Bio Chief Executive Officer Program at Seoul National University.